Market Overview:
Ultrasonic tissue ablation system is a technology that uses high-frequency sound waves to destroy or remove tissues. The global ultrasonic tissue ablation system market is expected to grow from USD 1.5 billion in 2018 to USD 3.2 billion by 2030, at a CAGR of 10.8% during the forecast period. This growth can be attributed to the increasing incidence of cancer and other diseases, growing demand for minimally invasive surgeries, and rising number of surgical procedures performed in hospitals and ambulatory surgical centers (ASCs). The high-intensity focused ultrasound (HIFU) ablators segment is expected to account for the largest share of the global ultrasonic tissue ablation system market in 2018. This segment is also projected to grow at the highest CAGR during the forecast period owing to its advantages such as precision targeting, less damage inflicted on healthy tissues around tumors, and shorter treatment time as compared with other modalities such as radiofrequency (RF) or microwave ablation systems. The hospital segment is expected to account for the largest share of the global ultrasonic tissue ablation system market in 2018.
Product Definition:
Ultrasonic tissue ablation system is a device which uses ultrasound to remove tissues. It is used to remove tumors, lesions or other abnormal tissues. Ultrasound energy creates heat which destroys the tissue. The system is important because it allows for precise and controlled removal of tissues without causing damage to surrounding healthy tissues.
High-intensity Focused Ultrasonic (HIFU) Ablators:
High-intensity Focused Ultrasonic (HIFU) ablators are used for the treatment of kidney, liver, breast and other cancerous tumors. HIFU is a noninvasive surgical procedure that uses high-intensity focused ultrasound waves to destroy tissues or organs without affecting the surrounding areas. The process is painless and has no immediate side effects; hence it can be used in patients suffering from heart diseases as well.
Magnetic Resonance-guided Focused Ultrasonic (MRGFUS) Ablators:
MR-guided Focused Ultrasonic (MRGFUS) ablators and it’s usage in the Ultrasonic Tissue Ablation System market. MR-guided focused ultrasonic (MRGFUS) ablators are devices that use high frequency sound waves to destroy tissues by causing coagulative necrosis of cells.
Application Insights:
Based on application, the market is segmented into hospital, ambulatory surgical centers, clinics and specialty care units and other facilities. The others segment includes research institutes and educational institutions. Ambulatory surgical centers dominated the market in 2017 owing to factors such as increasing awareness about minimally invasive procedures among consumers as well as healthcare providers. Minimally invasive procedures are associated with less postoperative pain & trauma compared to conventional surgeries which encourages more people to seek treatment at ASCs over hospitals. Ultrasonic tissue ablation systems allow doctors at ASCs to offer their patients better quality of life by reducing pain & suffering caused by cancerous tumors or cysts without removing them from the body since these systems enable accurate targeting of tumors & cysts while minimizing damage to surrounding healthy organs.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to increasing R&D investments by key players, rising adoption of technologically advanced products, and growing demand for minimally invasive surgeries. In addition, the presence of well-established healthcare facilities and a large number of ambulatory surgical centers are some other factors contributing toward regional growth.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to improving healthcare infrastructure in countries such as India and China along with government initiatives promoting medical tourism. These factors are anticipated to boost demand for ultrasonic tissue ablation systems during the forecast period.
Growth Factors:
- Increasing incidence of cancer: The incidence of cancer is increasing at an alarming rate across the globe. This is expected to drive the demand for Ultrasonic Tissue Ablation System market as they are used for the treatment of various types of cancers.
- Technological advancements: The Ultrasonic Tissue Ablation System market is witnessing rapid technological advancements, which is likely to fuel its growth in the coming years.
- Rising awareness about minimally invasive procedures: There is a growing awareness among people about minimally invasive procedures and their benefits over traditional surgeries. This is likely to boost demand for Ultrasonic Tissue Ablation System in the coming years.
- Growing number of surgical procedures: The number of surgical procedures being performed globally has been on the rise in recent years, owing to factors such as rising prevalence of chronic diseases and increasing disposable income levels among consumers worldwide .This will create opportunities for players operating in Ultrasonic Tissue Ablation System market . 5)Rising healthcare expenditure: Healthcare expenditure around the world has been on a rise due to increase in prevalence rates off chronic diseases and other lifestyle-related disorders
Scope Of The Report
Report Attributes
Report Details
Report Title
Ultrasonic Tissue Ablation System Market Research Report
By Type
High-intensity Focused Ultrasonic (HIFU) Ablators, Magnetic Resonance-guided Focused Ultrasonic (MRGFUS) Ablators, Ultrasonic Surgical Ablation Systems, Shock wave therapy Systems
By Application
Hospital, Ambulatory Surgical centers, Clinics, Specialty Care Unit, Others
By Companies
Ethicon, Inc., Johnson & Johnson, Misonix Inc., SonaCare Medical, LLC., INSIGHTEC Ltd, Integra LifeSciences Corporation, Alpinion Medical Systems, Chongqing Haifu Medical Technology Co., Ltd
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
245
Number of Tables & Figures
172
Customization Available
Yes, the report can be customized as per your need.
Global Ultrasonic Tissue Ablation System Market Report Segments:
The global Ultrasonic Tissue Ablation System market is segmented on the basis of:
Types
High-intensity Focused Ultrasonic (HIFU) Ablators, Magnetic Resonance-guided Focused Ultrasonic (MRGFUS) Ablators, Ultrasonic Surgical Ablation Systems, Shock wave therapy Systems
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Ambulatory Surgical centers, Clinics, Specialty Care Unit, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Ethicon, Inc.
- Johnson & Johnson
- Misonix Inc.
- SonaCare Medical, LLC.
- INSIGHTEC Ltd
- Integra LifeSciences Corporation
- Alpinion Medical Systems
- Chongqing Haifu Medical Technology Co., Ltd
Highlights of The Ultrasonic Tissue Ablation System Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- High-intensity Focused Ultrasonic (HIFU) Ablators
- Magnetic Resonance-guided Focused Ultrasonic (MRGFUS) Ablators
- Ultrasonic Surgical Ablation Systems
- Shock wave therapy Systems
- By Application:
- Hospital
- Ambulatory Surgical centers
- Clinics
- Specialty Care Unit
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Ultrasonic Tissue Ablation System Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Ultrasonic tissue ablation system is a medical device that uses high-frequency sound waves to destroy unwanted tissues.
Some of the major companies in the ultrasonic tissue ablation system market are Ethicon, Inc., Johnson & Johnson, Misonix Inc., SonaCare Medical, LLC., INSIGHTEC Ltd, Integra LifeSciences Corporation, Alpinion Medical Systems, Chongqing Haifu Medical Technology Co., Ltd.
The ultrasonic tissue ablation system market is expected to grow at a compound annual growth rate of 10.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Ultrasonic Tissue Ablation System Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Ultrasonic Tissue Ablation System Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Ultrasonic Tissue Ablation System Market - Supply Chain
4.5. Global Ultrasonic Tissue Ablation System Market Forecast
4.5.1. Ultrasonic Tissue Ablation System Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Ultrasonic Tissue Ablation System Market Size (000 Units) and Y-o-Y Growth
4.5.3. Ultrasonic Tissue Ablation System Market Absolute $ Opportunity
5. Global Ultrasonic Tissue Ablation System Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Ultrasonic Tissue Ablation System Market Size and Volume Forecast by Type
5.3.1. High-intensity Focused Ultrasonic (HIFU) Ablators
5.3.2. Magnetic Resonance-guided Focused Ultrasonic (MRGFUS) Ablators
5.3.3. Ultrasonic Surgical Ablation Systems
5.3.4. Shock wave therapy Systems
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Ultrasonic Tissue Ablation System Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Ultrasonic Tissue Ablation System Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Ambulatory Surgical centers
6.3.3. Clinics
6.3.4. Specialty Care Unit
6.3.5. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Ultrasonic Tissue Ablation System Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Ultrasonic Tissue Ablation System Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Ultrasonic Tissue Ablation System Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Ultrasonic Tissue Ablation System Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Ultrasonic Tissue Ablation System Demand Share Forecast, 2019-2026
9. North America Ultrasonic Tissue Ablation System Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Ultrasonic Tissue Ablation System Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Ultrasonic Tissue Ablation System Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Ambulatory Surgical centers
9.4.3. Clinics
9.4.4. Specialty Care Unit
9.4.5. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Ultrasonic Tissue Ablation System Market Size and Volume Forecast by Type
9.7.1. High-intensity Focused Ultrasonic (HIFU) Ablators
9.7.2. Magnetic Resonance-guided Focused Ultrasonic (MRGFUS) Ablators
9.7.3. Ultrasonic Surgical Ablation Systems
9.7.4. Shock wave therapy Systems
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Ultrasonic Tissue Ablation System Demand Share Forecast, 2019-2026
10. Latin America Ultrasonic Tissue Ablation System Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Ultrasonic Tissue Ablation System Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Ultrasonic Tissue Ablation System Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Ambulatory Surgical centers
10.4.3. Clinics
10.4.4. Specialty Care Unit
10.4.5. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Ultrasonic Tissue Ablation System Market Size and Volume Forecast by Type
10.7.1. High-intensity Focused Ultrasonic (HIFU) Ablators
10.7.2. Magnetic Resonance-guided Focused Ultrasonic (MRGFUS) Ablators
10.7.3. Ultrasonic Surgical Ablation Systems
10.7.4. Shock wave therapy Systems
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Ultrasonic Tissue Ablation System Demand Share Forecast, 2019-2026
11. Europe Ultrasonic Tissue Ablation System Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Ultrasonic Tissue Ablation System Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Ultrasonic Tissue Ablation System Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Ambulatory Surgical centers
11.4.3. Clinics
11.4.4. Specialty Care Unit
11.4.5. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Ultrasonic Tissue Ablation System Market Size and Volume Forecast by Type
11.7.1. High-intensity Focused Ultrasonic (HIFU) Ablators
11.7.2. Magnetic Resonance-guided Focused Ultrasonic (MRGFUS) Ablators
11.7.3. Ultrasonic Surgical Ablation Systems
11.7.4. Shock wave therapy Systems
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Ultrasonic Tissue Ablation System Demand Share, 2019-2026
12. Asia Pacific Ultrasonic Tissue Ablation System Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Ultrasonic Tissue Ablation System Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Ultrasonic Tissue Ablation System Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Ambulatory Surgical centers
12.4.3. Clinics
12.4.4. Specialty Care Unit
12.4.5. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Ultrasonic Tissue Ablation System Market Size and Volume Forecast by Type
12.7.1. High-intensity Focused Ultrasonic (HIFU) Ablators
12.7.2. Magnetic Resonance-guided Focused Ultrasonic (MRGFUS) Ablators
12.7.3. Ultrasonic Surgical Ablation Systems
12.7.4. Shock wave therapy Systems
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Ultrasonic Tissue Ablation System Demand Share, 2019-2026
13. Middle East & Africa Ultrasonic Tissue Ablation System Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Ultrasonic Tissue Ablation System Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Ultrasonic Tissue Ablation System Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Ambulatory Surgical centers
13.4.3. Clinics
13.4.4. Specialty Care Unit
13.4.5. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Ultrasonic Tissue Ablation System Market Size and Volume Forecast by Type
13.7.1. High-intensity Focused Ultrasonic (HIFU) Ablators
13.7.2. Magnetic Resonance-guided Focused Ultrasonic (MRGFUS) Ablators
13.7.3. Ultrasonic Surgical Ablation Systems
13.7.4. Shock wave therapy Systems
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Ultrasonic Tissue Ablation System Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Ultrasonic Tissue Ablation System Market: Market Share Analysis
14.2. Ultrasonic Tissue Ablation System Distributors and Customers
14.3. Ultrasonic Tissue Ablation System Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Ethicon, Inc.
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Johnson & Johnson
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Misonix Inc.
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. SonaCare Medical, LLC.
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. INSIGHTEC Ltd
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Integra LifeSciences Corporation
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Alpinion Medical Systems
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Chongqing Haifu Medical Technology Co., Ltd
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2.
